Desq Long
Sign in

Company

SUPERNUS PHARMACEUTICALS, INC.

SUPN · CIK 0001356576

SEC FORM 4
$0.00

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Acquisition (code M) of 1,250 shares at $0 per share.

Reporting Person DEC TIMOTHY C · Officer Title Senior Vice-President & CFO · Transaction Code M

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001194020-26-000015 · filed 2026-08-14 · View filing →

SEC FORM 4
$28,128.28

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Disposition (code F) of 604 shares at $46.57 per share.

Reporting Person DEC TIMOTHY C · Officer Title Senior Vice-President & CFO · Transaction Code F

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001194020-26-000015 · filed 2026-08-14 · View filing →

SEC FORM 4
$0.00

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Acquisition (code M) of 2,500 shares at $0 per share.

Reporting Person Bhatt Padmanabh P. · Officer Title Sr. VP of IP, CSO · Transaction Code M

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001539215-26-000012 · filed 2026-08-14 · View filing →

SEC FORM 4
$53,928.06

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Disposition (code F) of 1,158 shares at $46.57 per share.

Reporting Person Bhatt Padmanabh P. · Officer Title Sr. VP of IP, CSO · Transaction Code F

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001539215-26-000012 · filed 2026-08-14 · View filing →

SEC FORM 4
$0.00

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Acquisition (code M) of 29,849 shares at $0 per share.

Reporting Person Khattar Jack A. · Officer Title President, CEO · Transaction Code M

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001539937-26-000012 · filed 2026-08-14 · View filing →

SEC FORM 4
$588,737.94

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Disposition (code F) of 12,642 shares at $46.57 per share.

Reporting Person Khattar Jack A. · Officer Title President, CEO · Transaction Code F

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001539937-26-000012 · filed 2026-08-14 · View filing →

SEC FORM 4
$0.00

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Acquisition (code M) of 1,650 shares at $0 per share.

Reporting Person Mottola Frank · Officer Title SVP, Chief Tech. Ops. Officer · Transaction Code M

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001804567-26-000014 · filed 2026-08-14 · View filing →

SEC FORM 4
$37,116.29

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Disposition (code F) of 797 shares at $46.57 per share.

Reporting Person Mottola Frank · Officer Title SVP, Chief Tech. Ops. Officer · Transaction Code F

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001804567-26-000014 · filed 2026-08-14 · View filing →

SEC FORM 4
$0.00

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Acquisition (code M) of 750 shares at $0 per share.

Reporting Person Rubin Jonathan · Officer Title SVP, Chief Medical Officer · Transaction Code M

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001836067-26-000010 · filed 2026-08-14 · View filing →

SEC FORM 4
$16,904.91

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Disposition (code F) of 363 shares at $46.57 per share.

Reporting Person Rubin Jonathan · Officer Title SVP, Chief Medical Officer · Transaction Code F

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001836067-26-000010 · filed 2026-08-14 · View filing →